15
Gil Harari Statistical considerations in clinical trials www.medistat.c o.il

Gil Harari Statistical considerations in clinical trials

Embed Size (px)

Citation preview

Gil Harari

Statistical considerations in clinical trials

www.medistat.co.il

Elephants, Diamonds & Biostatistics ???

Analyses Variables

• Primary Efficacy Variables

• Secondary Efficacy Variables

• Safety Variable Adverse Events. Physical examinations. Laboratory measurements . Reasons for discontinuation.

Statistical considerations in biomedical studies

Is risk factor X associated with disease Y?

From the sample, we compute an estimate of the effect of X on Y (e.g., risk ratio if cohort study):

-Is the effect real? Did chance play a role?

Why worry about chance?

Population

Sampling variability… -you only get to pick one sample!

Interpreting the results

PopulationSelection of subjects

Inference

Make inferences from data collected using laws of probability and statistics

-tests of significance (p-value) -confidence intervals

How do we determine if an association is significant?

• Significance is in context of “Statistical” significance

– p-Value – Treatment Effect– Confidence Interval

8

Subjects for Discussion

1. What is a p-Value?

2. Sample Size Calculation

3. Clinical Significance Versus Statistical Significance

Basic Principles of Statistical Analysis

Significance Tests

Difference Between Treatments

Is it by chance?

Apply a significance test

Sample Size Calculations

Sample Size Calculation

Sample Size Calculation

Based on:

1 .Study Design

2 .Treatment Effect (Effect Size) (δ)

3 .Type I error (α), Type II error (β)

4. Power of the study (1-β)

Clinical significance Versus Statistical Significance

CR

TA

%Im

prov

emen

t %Im

prov

emen

t

43%

65%

Clinical Significance Statistical Significance

P=0.17

P=0.03

TBCR

52%

41%

N = 15 N = 60

תודה